Review
doi: 10.2450/2011.0031-11. Epub 2012 Oct 25.Hypercoagulability in congenital haemolytic anaemias
Affiliations
- PMID:22044960
- PMCID: PMC3496237
- DOI: 10.2450/2011.0031-11
Item in Clipboard
Review
Hypercoagulability in congenital haemolytic anaemias
Massimo Franchini et al. Blood Transfus.2012 Oct.
Display options
Format
Display options
Format
No abstract available
Similar articles
- Hereditary haemolytic anaemias and parvovirus infections in Jehovah's Witnesses.Barton CJ, Chowdhury V, Mabin D.Barton CJ, et al.Br J Haematol. 2003 May;121(4):675-6. doi: 10.1046/j.1365-2141.2003.04348.x.Br J Haematol. 2003.PMID:12752115No abstract available.
- The hereditary haemolytic anaemias.Dacie JV.Dacie JV.J R Coll Physicians Lond. 1974 Apr;8(3):206-19.J R Coll Physicians Lond. 1974.PMID:4824998Free PMC article.No abstract available.
- [Congenital hemolytic anemia with spherocytosis and erythrocyte cationic abnormalities].Afifi F, Bernard JF, Boivin P.Afifi F, et al.Ann Med Interne (Paris). 1973 Apr;124(4):317.Ann Med Interne (Paris). 1973.PMID:4720418French.No abstract available.
- Haemolytic anaemias due to enzyme deficiencies.Luzzatto L.Luzzatto L.Schweiz Med Wochenschr Suppl. 1991;43:103-5.Schweiz Med Wochenschr Suppl. 1991.PMID:1843031Review.No abstract available.
- Congenital Hemolytic Anemia.Haley K.Haley K.Med Clin North Am. 2017 Mar;101(2):361-374. doi: 10.1016/j.mcna.2016.09.008. Epub 2016 Dec 8.Med Clin North Am. 2017.PMID:28189176Review.
Cited by
- Thalassemia and Moyamoya syndrome: unfurling an intriguing association.Das S, Dubey S, Acharya M, Chatterjee S, Lahiri D, Das G, Ray BK, Kraemer M.Das S, et al.J Neurol. 2019 Nov;266(11):2838-2847. doi: 10.1007/s00415-019-09497-5. Epub 2019 Aug 17.J Neurol. 2019.PMID:31422456Review.
- Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients.Hatairaktham S, Masaratana P, Hantaweepant C, Srisawat C, Sirivatanauksorn V, Siritanaratkul N, Panichkul N, Kalpravidh RW.Hatairaktham S, et al.Ann Hematol. 2021 Apr;100(4):891-901. doi: 10.1007/s00277-020-04379-7. Epub 2021 Jan 3.Ann Hematol. 2021.PMID:33388858Clinical Trial.
- ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.Demagny J, Driss A, Stepanian A, Anguel N, Affo L, Roux D, Habibi A, Benghezal S, Capdenat S, Coppo P, Driss F, Veyradier A.Demagny J, et al.Res Pract Thromb Haemost. 2020 Dec 18;5(1):197-203. doi: 10.1002/rth2.12460. eCollection 2021 Jan.Res Pract Thromb Haemost. 2020.PMID:33537544Free PMC article.
References
- Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353:1135–46. - PubMed
- Franchini M, Gandini G, Aprili G. Advances in iron chelating therapy. Haematologica. 2000;85:1122–5. - PubMed
- Franchini M. Recent acquisitions in the management of iron overload. Ann Hematol. 2005;84:640–5. - PubMed
- Ataga KI, Cappellini MD, Rachmilewitz EA. β-Thalassemia and sickle cell anemia as paradigms of hypercoagulability. Br J Haematol. 2009;139:3–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources